CDC, FDA hid stroke risk linked to Pfizer’s COVID booster in seniors, Senate investigation reveals Federal agencies (FDA/CDC) identified a “moderately elevated” stroke risk in seniors post-Pfizer bivalent booster as early as October 2022—but never warned the public, despite 7 internal analyses confirming the signal. Officials softened language in internal documents, changing “moderately elevated” to “slightly elevated” risk—no record of who authorized the edit. While J&J’s vaccine was paused in 2021 over six blood clot cases, the Biden administration ignored 226+ stroke cases linked to Pfizer’s booster—prioritizing politics over safety. CDC/FDA acted as Big Pharma marketing arms, suppressing risks to protect profits—corrupting…

Newswire

Features

The Latest

Editor's Picks